Tagged: Drug Development

Antifungal Resistance: A Global Health Threat

Antibiotic resistance receives lots of media attention, being a huge threat to global public health. But an equally concerning problem remains a relative unknown to the general public: antifungal resistance. Fungal infections have the potential to cause rashes, mild inflammations,...

monoclonal antibodies antigen binding protein interaction

Monoclonal Antibodies in Drug Development

The global monoclonal antibody market has an annual value of USD 100 billion, boasting blockbuster drugs such as Humira and Keytruda. Monoclonal antibodies are immune cells that have the ability to bind to very specific targets. By doing so, they...

epigenetics mechanism DNA methylation methyl groups binding to helix

Epigenetic Therapies for Treatment of Mental Disorders

Mental health disorders range from anxiety and depression to schizophrenia and dementia, affecting a significant number of people worldwide. Current treatments tend to be short-term and carry high risks of withdrawal symptoms, among other adverse side effects. Epigenetic therapies are...

CRISPR gene editing engineering therapy

What’s the Big Deal About Gene Therapy?

2017/18 could well turn out to be revolutionary in the history – and perhaps more so the future – of medicine. In August 2017, the US Food and Drug Administration (FDA) gave its first gene therapy approval to Kymriah for...